GSK's Avandia woes spark talk of cuts
Stephen McGuire
October 01 2007
UK drugmaker GlaxoSmithKline is eyeing cuts to its sales force in response to declining sales of its type 2 diabetes ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.